Completed PHASE2 INTERVENTIONAL 2-arm
NCT00900991
Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children
Sponsor: Centers for Disease Control and Prevention, China
Conditions
Influenza
Updated 5 times since 2017 Last updated: May 13, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Influenza, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention, China and has accumulated 5 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Centers for Disease Control and Prevention, China
- Sinovac Biotech Co., Ltd
Data source: Sinovac Biotech Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .